Stock HEXCARE RUBBEREX CORPORATION (M)
Add to a list
To use this feature you must be a member
Log inSign up

Financials Rubberex Corporation (M)

Equities

HEXCARE

MYL7803OO009

Medical Equipment, Supplies & Distribution

End-of-day quote BURSA MALAYSIA
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
0.205 MYR +2.50% Intraday chart for Rubberex Corporation (M) -2.38% -29.31%
Apr. 08 Hextar Healthcare Berhad Announces the Resignation of Wong Yee Leng as Company Secretary CI
Apr. 08 Hextar Healthcare Berhad Announces the Appointment of Ong Wai Leng as Company Secretary CI

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 170.2 113.5 136.2 1,164 454.4 370.7
Enterprise Value (EV) 1 206.4 134 92.98 1,005 157.9 366.9
P/E ratio 12.5 x -2.18 x 5.14 x 8.57 x 2.38 x -5.95 x
Yield 2.58% 3.87% 3.72% - - -
Capitalization / Revenue 0.42 x 0.55 x 0.62 x 2.79 x 0.88 x 2.07 x
EV / Revenue 0.51 x 0.65 x 0.42 x 2.41 x 0.31 x 2.05 x
EV / EBITDA 4.13 x 3.8 x 3.3 x 5.82 x 0.65 x -12.8 x
EV / FCF 9.77 x -4.92 x 0.95 x 22.2 x 2.57 x 2.32 x
FCF Yield 10.2% -20.3% 105% 4.49% 38.9% 43.1%
Price to Book 0.62 x 0.53 x 0.66 x 3.08 x 0.76 x 0.61 x
Nbr of stocks (in thousands) 756,617 756,587 756,587 831,108 873,903 1,001,920
Reference price 2 0.2250 0.1500 0.1800 1.400 0.5200 0.3700
Announcement Date 4/20/18 4/30/19 5/29/20 4/22/21 4/28/22 4/27/23
1MYR in Million2MYR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 403.6 205.4 219.5 416.6 514.7 179
EBITDA 1 49.97 35.31 28.17 172.8 242.5 -28.57
EBIT 1 25.13 11.57 21.12 164.8 230 -43
Operating Margin 6.23% 5.63% 9.62% 39.56% 44.68% -24.02%
Earnings before Tax (EBT) 1 15.24 10.14 15.74 161 236.8 -63.18
Net income 1 13.17 -52.09 26.51 131.2 185.7 -55.69
Net margin 3.26% -25.35% 12.08% 31.48% 36.09% -31.1%
EPS 2 0.0180 -0.0688 0.0350 0.1634 0.2181 -0.0622
Free Cash Flow 1 21.13 -27.25 97.5 45.17 61.35 158.1
FCF margin 5.24% -13.26% 44.42% 10.84% 11.92% 88.29%
FCF Conversion (EBITDA) 42.29% - 346.16% 26.14% 25.3% -
FCF Conversion (Net income) 160.4% - 367.8% 34.44% 33.03% -
Dividend per Share 2 0.005800 0.005800 0.006700 - - -
Announcement Date 4/20/18 4/30/19 5/29/20 4/22/21 4/28/22 4/27/23
1MYR in Million2MYR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 36.1 20.5 - - - -
Net Cash position 1 - - 43.2 159 297 3.84
Leverage (Debt/EBITDA) 0.7229 x 0.5817 x - - - -
Free Cash Flow 1 21.1 -27.2 97.5 45.2 61.3 158
ROE (net income / shareholders' equity) 4.99% 3.54% 5.41% 45% 38% -9.24%
ROA (Net income/ Total Assets) 3.91% 2.04% 4.68% 27.8% 25.3% -3.96%
Assets 1 337.2 -2,549 567 471.9 734.4 1,406
Book Value Per Share 2 0.3700 0.2800 0.2700 0.4500 0.6900 0.6000
Cash Flow per Share 2 0.0400 0.0300 0.0700 0.0300 0.0100 0.0100
Capex 1 17 18.9 31.2 61.6 35.2 14.7
Capex / Sales 4.2% 9.2% 14.21% 14.79% 6.84% 8.18%
Announcement Date 4/20/18 4/30/19 5/29/20 4/22/21 4/28/22 4/27/23
1MYR in Million2MYR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
RUBBEREX CORPORATION (M) Stock Rubberex Corporation (M)
-29.31% 43.08M
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. HEXCARE Stock
  4. Financials Rubberex Corporation (M)